MANUELA CASTRO: Open Payments
NPI 1366229072 · PRINCETON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $709
Food & beverage: $654Education: $55
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 6 | $187 |
| Axsome Therapeutics, Inc. | 2 | $146 |
| Smith+Nephew, Inc. | 1 | $59 |
| GENZYME CORPORATION | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 1 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $49 |
| HARMONY BIOSCIENCES LLC | 2 | $42 |
| Integra LifeSciences Corporation | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $15 |
Products named: NUCALA, DUPIXENT, Sunosi, TULA, NEFFY, WAKIX, ACCLARENT AERA, ZEPBOUND.
Industry payments across NJ — which companies pay providers there.
